| Development of functional human blood and immune systems in NOD/SCID/IL2 receptor γ chainnull mice F Ishikawa, M Yasukawa, B Lyons, S Yoshida, T Miyamoto, G Yoshimoto, ... Blood 106 (5), 1565-1573, 2005 | 1131 | 2005 |
| The first identification and retrospective study of severe fever with thrombocytopenia syndrome in Japan T Takahashi, K Maeda, T Suzuki, A Ishido, T Shigeoka, T Tominaga, ... The Journal of infectious diseases 209 (6), 816-827, 2014 | 813 | 2014 |
| Nationwide survey of hemophagocytic lymphohistiocytosis in Japan E Ishii, S Ohga, S Imashuku, M Yasukawa, H Tsuda, I Miura, K Yamamoto, ... International journal of hematology 86, 58-65, 2007 | 555 | 2007 |
| HLA class I-restricted lysis of leukemia cells by a CD8+ cytotoxic T-lymphocyte clone specific for WT1 peptide H Ohminami, M Yasukawa, S Fujita Blood, The Journal of the American Society of Hematology 95 (1), 286-293, 2000 | 460 | 2000 |
| Generation of functional human T-cell subsets with HLA-restricted immune responses in HLA class I expressing NOD/SCID/IL2rγnull humanized mice LD Shultz, Y Saito, Y Najima, S Tanaka, T Ochi, M Tomizawa, T Doi, ... Proceedings of the National Academy of Sciences 107 (29), 13022-13027, 2010 | 406 | 2010 |
| Association of human herpesvirus 6 reactivation with the flaring and severity of drug‐induced hypersensitivity syndrome M Tohyama, K Hashimoto, M Yasukawa, H Kimura, T Horikawa, ... British Journal of Dermatology 157 (5), 934-940, 2007 | 363 | 2007 |
| Severe hypersensitivity syndrome due to sulfasalazine associated with reactivation of human herpesvirus 6 M Tohyama, Y Yahata, M Yasukawa, R Inagi, Y Urano, K Yamanishi, ... Archives of dermatology 134 (9), 1113-1117, 1998 | 343 | 1998 |
| Identification of N-arachidonylglycine as the endogenous ligand for orphan G-protein-coupled receptor GPR18 M Kohno, H Hasegawa, A Inoue, M Muraoka, T Miyazaki, K Oka, ... Biochemical and biophysical research communications 347 (3), 827-832, 2006 | 311 | 2006 |
| Epstein–Barr virus‐encoded poly (A)− RNA supports Burkitt's lymphoma growth through interleukin‐10 induction N Kitagawa, M Goto, K Kurozumi, S Maruo, M Fukayama, T Naoe, ... The EMBO journal, 2000 | 275 | 2000 |
| Improved expression and reactivity of transduced tumor-specific TCRs in human lymphocytes by specific silencing of endogenous TCR S Okamoto, J Mineno, H Ikeda, H Fujiwara, M Yasukawa, H Shiku, I Kato Cancer research 69 (23), 9003-9011, 2009 | 258 | 2009 |
| Human cytotoxic T cell clones directed against herpes simplex virus-infected cells. I. Lysis restricted by HLA class II MB and DR antigens. M Yasukawa, JM Zarling Journal of immunology (Baltimore, Md.: 1950) 133 (1), 422-427, 1984 | 215 | 1984 |
| Granule exocytosis, and not the Fas/Fas ligand system, is the main pathway of cytotoxicity mediated by alloantigen-specific CD4+ as well as CD8+ cytotoxic T … M Yasukawa, H Ohminami, J Arai, Y Kasahara, Y Ishida, S Fujita Blood, The Journal of the American Society of Hematology 95 (7), 2352-2355, 2000 | 193 | 2000 |
| HLA class I binding of HBZ determines outcome in HTLV-1 infection A MacNamara, A Rowan, S Hilburn, U Kadolsky, H Fujiwara, K Suemori, ... PLoS pathogens 6 (9), e1001117, 2010 | 171 | 2010 |
| Identification of human telomerase reverse transcriptase–derived peptides that induce HLA-A24–restricted antileukemia cytotoxic T lymphocytes J Arai, M Yasukawa, H Ohminami, M Kakimoto, A Hasegawa, S Fujita Blood, The Journal of the American Society of Hematology 97 (9), 2903-2907, 2001 | 165 | 2001 |
| Isolation of a T-cell clone showing HLA-DRB1* 0405-restricted cytotoxicity for hematopoietic cells in a patient with aplastic anemia S Nakao, A Takami, H Takamatsu, W Zeng, N Sugimori, H Yamazaki, ... Blood, The Journal of the American Society of Hematology 89 (10), 3691-3699, 1997 | 163 | 1997 |
| Enhanced induction of human WT1-specific cytotoxic T lymphocytes with a 9-mer WT1 peptide modified at HLA-A* 2402-binding residues A Tsuboi, Y Oka, K Udaka, M Murakami, T Masuda, A Nakano, ... Cancer Immunology, Immunotherapy 51, 614-620, 2002 | 162 | 2002 |
| Safety and persistence of WT1-specific T-cell receptor gene− transduced lymphocytes in patients with AML and MDS I Tawara, S Kageyama, Y Miyahara, H Fujiwara, T Nishida, Y Akatsuka, ... Blood, The Journal of the American Society of Hematology 130 (18), 1985-1994, 2017 | 160 | 2017 |
| Novel adoptive T-cell immunotherapy using a WT1-specific TCR vector encoding silencers for endogenous TCRs shows marked antileukemia reactivity and safety T Ochi, H Fujiwara, S Okamoto, J An, K Nagai, T Shirakata, J Mineno, ... Blood, The Journal of the American Society of Hematology 118 (6), 1495-1503, 2011 | 160 | 2011 |
| Perforin gene mutations in adult-onset hemophagocytic lymphohistiocytosis K Nagafuji, A Nonami, T Kumano, Y Kikushige, G Yoshimoto, K Takenaka, ... Haematologica 92 (7), 978-981, 2007 | 159 | 2007 |
| Wilms tumor gene peptide-based immunotherapy for patients with overt leukemia from myelodysplastic syndrome (MDS) or MDS with myelofibrosis Y Oka, A Tsuboi, M Murakami, M Hirai, N Tominaga, H Nakajima, ... International journal of hematology 78, 56-61, 2003 | 159 | 2003 |
